Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
Latest Information Update: 22 Jul 2024
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Pharmacodynamics
Most Recent Events
- 16 Jul 2024 Phase changed from II to early phase I.
- 16 Jul 2024 Status changed from completed to discontinued.(Reason the study was stopped: The study was initially paused due to COVID restrictions and then when able to resume, there was no longer funding.)
- 05 Dec 2022 Status changed from active, no longer recruiting to completed.